Novartis AG (NOVN.SW) Stock Price, News, Quote & History - Yahoo Finance
Oops, something went wrong
Skip to navigation
Skip to main content
Skip to right column
News
Today's news
US
Politics
World
Weather
Climate change
Health
Wellness
Mental health Sexual health Dermatology Oral health Hair loss Foot health
Nutrition
Healthy eating Meal delivery Weight loss Vitamins and supplements
Fitness
Equipment Exercise
Women’s health
Sleep
Healthy aging
Hearing Mobility
Science
Originals
The 360
Newsletters
Games
Life
Health
Wellness
Nutrition Fitness Healthy aging Mental health Sleep
Your body
Dermatology Children's health Foot health Hair loss Hearing Oral health Sexual health Women’s health
Conditions
Cardiovascular health Digestive health Endocrine system
Parenting
Family health
So mini ways
Style and beauty
It Figures
Unapologetically
Horoscopes
Shopping
Style
Accessories Clothing Luggage Shoes
Beauty
Hair Makeup Skincare Sunscreen
Health
Dental Fitness Hair loss Hearing aids Mental health Mobility Nutrition Personal care Sleep Women's health
Home and garden
Bedding Cleaning Gardening Kitchen Outdoor
Pets
Tech
Accessories Audio Auto Computers Phones Smart home TVs
Gift ideas
Stores
Amazon Best Buy Home Depot Macy's Nordstrom Target Walmart Wayfair
Shopping Guides
Best non-toxic cutting boards Best heated socks Best body wash Best cordless stick vacuums Best makeup removers
Deals
Food
Travel
Autos
EV & Future Tech
Classic & Collector
Deals & Buying Guides
Ownership
Safety & Recalls
Policy & Environment
New Vehicles & Reviews
Auto Shows
General
People & Culture
Gift ideas
Buying guides
Best Prime Day deals
Prime Day tech deals
October Prime Day deals
Entertainment
Celebrity
TV
Movies
Music
How to Watch
Interviews
Videos
Finance
My Portfolio
News
Latest
Stock Market
Originals
Crypto
Tariff Updates
Newsletters
Economies
Premium News
Earnings
Tech
Housing
Markets
Stocks: Most Actives
Stocks: Gainers
Stocks: Losers
Trending Tickers
Futures
World Indices
US Treasury Bonds Rates
Currencies
Crypto
Top ETFs
Top Mutual Funds
Options: Highest Open Interest
Options: Highest Implied Volatility
Sectors
Basic Materials
Communication Services
Consumer Cyclical
Consumer Defensive
Energy
Financial Services
Healthcare
Industrials
Real Estate
Technology
Utilities
Private Companies
Research
Screeners
Earnings Calendar
Economic Calendar
Stock Comparison
Advanced Chart
Currency Converter
Stock Picks
Investment Ideas
Research Reports
Personal Finance
Credit Cards
Banking
Student Loans
Personal Loans
Insurance
Mortgages
Mortgage Calculator
Taxes
Videos
Latest
Trending Stocks
Market Sunrise
Morning Brief
Opening Bid
All Shows
Stocks in Translation
Trader Talk
Financial Freestyle
ETF Report
FA Corner
Options Playbook
Watch Now
Sports
Fantasy
News
Fantasy football
Best ball
Pro Pick 'Em
College Pick 'Em
Fantasy baseball
Fantasy hockey
Fantasy basketball
Download the app
Daily fantasy
NFL
News
Scores and schedules
Standings
Stats
Teams
Players
Drafts
Injuries
Odds
Super Bowl
GameChannel
Videos
NBA
News
Draft
Scores and schedules
Standings
Stats
Teams
Players
Injuries
Videos
Odds
Playoffs
MLB
News
Scores and schedules
Standings
Stats
Teams
Players
Odds
Videos
World Baseball Classic
NHL
News
Scores and schedules
Standings
Stats
Teams
Players
Odds
Playoffs
College football
News
Scores and schedules
Standings
Rankings
Stats
Teams
College basketball
Soccer
News
Scores and schedules
Premier League
MLS
NWSL
Liga MX
CONCACAF League
Champions League
La Liga
Serie A
Bundesliga
Ligue 1
World Cup
NFL Draft
Yahoo Sports AM
Show all
WNBA
Sportsbook
NCAAF
Tennis
Golf
NASCAR
NCAAB
NCAAW
Boxing
USFL
Cycling
Motorsports
Olympics
Horse racing
GameChannel
Rivals
Newsletters
Podcasts
Videos
RSS
Jobs
Help
World Cup
More news
New on Yahoo
Creators
Tech
Audio
Computing
Gaming
Connections Gaming deals Nintendo PC PlayStation Wordle Xbox
Home entertainment
TVs
Phones
Science
Streaming
Streaming reviews
Tech News
VPN
Deals
More
AI Apps AR and VR Business Cameras Cyber security Entertainment General Reviews and guides Smart home Social media Transportation Wearables
Local services
Moving
Roofing
Painting
Plumbing
Terms
Privacy
Privacy Dashboard
Feedback
© 2025
All rights reserved.
About our ads
Advertising
Careers
Yahoo Finance
Yahoo Finance
Search query
Select edition
USEnglish
US y LATAMEspañol
AustraliaEnglish
CanadaEnglish
CanadaFrançais
DeutschlandDeutsch
FranceFrançais
香港繁中
MalaysiaEnglish
New ZealandEnglish
SingaporeEnglish
台灣繁中
UKEnglish
News
Finance
Sports
More
News
Today's news
US
Politics
World
Weather
Climate change
Health
Science
Originals
Newsletters
Games
Life
Health
Parenting
Style and beauty
Horoscopes
Shopping
Food
Travel
Autos
Gift ideas
Buying guides
Best Prime Day deals
Prime Day tech deals
October Prime Day deals
Entertainment
Celebrity
TV
Movies
Music
How to Watch
Interviews
Videos
Finance
My portfolio
Watchlists
Markets
News
Videos
Screeners
Personal finance
Crypto
Sectors
Sports
Fantasy
NFL
NBA
MLB
NHL
College football
College basketball
Soccer
NFL Draft
Yahoo Sports AM
New on Yahoo Creators Tech Local services
Selected edition
USEnglish
Mail
Sign in
My Portfolio
News
Latest Stock Market Originals Crypto Tariff Updates Newsletters Economies Premium News
Earnings Tech Housing
Markets
Stocks: Most Actives Stocks: Gainers Stocks: Losers Trending Tickers Futures World Indices US Treasury Bonds Rates Currencies Crypto Top ETFs Top Mutual Funds Options: Highest Open Interest Options: Highest Implied Volatility Sectors Basic Materials Communication Services Consumer Cyclical Consumer Defensive Energy Financial Services Healthcare Industrials Real Estate Technology Utilities Private Companies
Research
Screeners Earnings Calendar Economic Calendar Stock Comparison Advanced Chart Currency Converter Stock Picks
Investment Ideas
Research Reports
Personal Finance
Credit Cards Banking Student Loans Personal Loans Insurance Mortgages Mortgage Calculator Taxes
Videos
Latest Trending Stocks Market Sunrise Morning Brief Opening Bid All Shows Stocks in Translation Trader Talk Financial Freestyle ETF Report FA Corner Options Playbook
Watch Now
…
Upgrade to Premium
NOVN.SW Novartis AG
97.83
+0.32%
Summary
News
Research
Chart
Community
Statistics
Historical Data
Profile
Financials
Analysis
Options
Holders
Sustainability
We are experiencing some temporary issues. The market data on this page is currently delayed.
Swiss - Delayed Quote • CHF
Novartis AG (NOVN.SW)
Follow
Add holdings
Get top stock picks
97.83
+0.31
+(0.32%)
At close: September 24 at 5:31:05 PM GMT+2
Get top stock picks
Chart Range Bar
1D
5D
1.29%
1M
-4.05%
6M
-1.41%
YTD
10.29%
1Y
-1.13%
5Y
26.94%
All
572.36%
Key Events
Mountain
Advanced Chart
Loading chart for NOVN.SW
Previous Close 97.52
Open 97.52
Bid --
Ask --
Day's Range 96.80 - 98.00
52 Week Range 81.10 - 104.62
Volume 2,152,126
Avg. Volume 2,646,459
Market Cap (intraday) 189.385B
Beta (5Y Monthly) 0.56
PE Ratio (TTM) 17.92
EPS (TTM) 5.46
Earnings Date Jul 17, 2025
Forward Dividend & Yield 3.50 (3.59%)
Ex-Dividend Date Mar 11, 2025
1y Target Est 98.58
Novartis AG Overview Drug Manufacturers - General / Healthcare
Novartis AG researches, develops, manufactures, distributes, markets, and sells pharmaceutical medicines in Switzerland and internationally. The company offers Entresto, an angiotensin receptorneprilysin inhibitor to treat symptomatic chronic heart failure with reduced ejection fraction (HFrEF); Cosentyx to treat plaque psoriasis, pso riatic arthritis, ankylosing spondylitis, and nonradiographic axial spondy loarthritis; Kisqali, a selective oral cyclin dependent inhibitor of kinases 4 and 6 (CDK4/6); Promacta/Revolade to treat immune thrombocytopenia (ITP), thrombocytopenia, and patients with severe aplastic anemia (SAA); Tafinlar+Mekinist, an oral combination therapy to treat patients with certain types of cancers; and Jakavi for the treatment of myelofibrosis, polycythemia vera, and acute or chronic graftversushost disease (GvHD). It also provides Tasigna to treat philadelphia chromosomepositive chronic myeloid leukemia in the chronic and/or accelerated phase; Xolair for the treatment of allergic asthma and nasal polyps or severe chronic rhinosi nusitis with nasal polyps; Ilaris to treat fever syndromes, Still's disease, and acute gouty arthritis; Pluvicto to treat prostatespecific membrane anti genpositive metastatic castrationresistant prostate cancer; Sandostatin SC and Sandostatin LAR to treat acromegaly carcinoid tumors and other types of functional gastro intestinal and pancreatic neuroendocrine tumors; Zolgensma for the treatment of genetic root cause of spinal muscular atrophy; Lucentis; Leqvio to reduce LDL cholesterol; Lutathera; Scemblix; and Fabhalta. The company focuses on therapeutic areas, such as cardiovascular, renal and metabolic, immunology, neuroscience, oncology, and hematology. It has a license and collaboration agreement with Alnylam Pharmaceuticals, Inc. to develop, manufacture, and commercialize Leqvio (inclisiran), a therapy to reduce LDL cholesterol. Novartis AG was incorporated in 1996 and is headquartered in Basel, Switzerland. www.novartis.com
75,883 Full Time Employees December 31 Fiscal Year Ends Healthcare
Sector Drug Manufacturers - General
Industry
More about Novartis AG
Recent News: NOVN.SW View More
All
News
Earnings Calls
Press Releases
SEC Filings
Humana Extends TailorCare Tie-Up to Enhance MA Member Health
Zacks • 7h ago
BIIB's sNDA for Higher Dose of SMA Drug Spinraza Gets FDA's CRL
Zacks • 8h ago
Zealand Pharma appoints Rachel James-Owens as Vice President, Corporate Communications & Media Relations
GlobeNewswire • 10h ago
Novartis (SWX:NOVN): Evaluating Current Valuation During a Period of Market Caution
Simply Wall St. • 13h ago
New Novartis data further support benefits of Kesimpta® in relapsing MS following switch from oral disease modifying therapies
GlobeNewswire • 18h ago
MLAB Biosciences Expands Scientific Advisory Board with Appointments of Peter Kang and Kathryn Wagner, Deepening Scientific Expertise in Neuromuscular Medicine
PR Newswire • 1d ago
Roche CEO, pharma execs to meet with Swiss government over US tariffs
Reuters • 2d ago
Cellares Appoints Former Kite Global Ops Leader, Christopher McDonald, to Board of Advisors
Business Wire • 2d ago
Novartis chief eyes ways to end higher US drug prices: media
AFP • 4d ago
Novartis has stockpiles to withstand potential Trump tariffs, CEO says
Reuters • 4d ago
INCY Obtains FDA Approval for Label Expansion of Ruxolitinib Cream
Zacks • 5d ago
View More
Performance Overview: NOVN.SW
Trailing total returns as of 9/24/2025, which may include dividends or other distributions. Benchmark is MSCI WORLD (^990100-USD-STRD)
.
YTD Return
NOVN.SW 14.24%
MSCI WORLD (^990100-USD-STRD) 15.04%
1-Year Return
NOVN.SW 2.40%
MSCI WORLD (^990100-USD-STRD) 15.99%
3-Year Return
NOVN.SW 55.88%
MSCI WORLD (^990100-USD-STRD) 75.44%
5-Year Return
NOVN.SW 54.96%
MSCI WORLD (^990100-USD-STRD) 85.55%
Compare To: NOVN.SW Compare
Select to analyze similar companies using key performance metrics; select up to 4 stocks.
NOVN.SW Novartis AG
97.83 +0.32%
Mkt Cap CHF 189.385B
Industry Drug Manufacturers—General
ROG.SW Roche Holding AG
259.90 -2.00%
Mkt Cap CHF 208.28B
Industry Drug Manufacturers—General
SAN.PA Sanofi
79.50 +0.30%
Mkt Cap EUR 96.873B
Industry Drug Manufacturers—General
AZN.L AstraZeneca PLC
11,210.00 -0.43%
Mkt Cap GBp 173.783B
Industry Drug Manufacturers—General
BAYN.DE Bayer Aktiengesellschaft
27.61 +0.36%
Mkt Cap EUR 27.125B
Industry Drug Manufacturers—General
GSK.L GSK plc
1,485.00 -0.60%
Mkt Cap GBp 59.773B
Industry Drug Manufacturers—General
RO.SW Roche Holding AG
273.00 -1.73%
Mkt Cap CHF 208.855B
Industry Drug Manufacturers—General
NOV.DE Novo Nordisk A/S
49.88 -0.80%
Mkt Cap EUR 221.107B
Industry Drug Manufacturers—General
NONOF Novo Nordisk A/S
59.55 -0.77%
Mkt Cap
263.005B
Industry Drug Manufacturers—General
BIIB Biogen Inc.
137.67 -1.18%
Mkt Cap
20.184B
Industry Drug Manufacturers—General
GLAXF GSK plc
20.35 +2.62%
Mkt Cap
81.984B
Industry Drug Manufacturers—General
Statistics: NOVN.SW View More
Valuation Measures
Current
Quarterly
Annual
As of 9/23/2025 Market Cap
188.78B
Enterprise Value
209.10B
Trailing P/E
17.85
Forward P/E
13.26
PEG Ratio (5yr expected)
1.28
Price/Sales
(ttm) 4.42
Price/Book
(mrq) 5.65
Enterprise Value/Revenue
4.78
Enterprise Value/EBITDA
11.62
Financial Highlights
Profitability and Income Statement
Profit Margin
24.74%
Return on Assets
(ttm) 11.87%
Return on Equity
(ttm) 32.49%
Revenue
(ttm) 55.19B
Net Income Avi to Common
(ttm) 13.65B
Diluted EPS
(ttm) 5.46
Balance Sheet and Cash Flow
Total Cash
(mrq) 6.73B
Total Debt/Equity
(mrq) 77.61%
Levered Free Cash Flow
(ttm) 14.68B
View More
Research Analysis: NOVN.SW View More
Earnings Per Share
Consensus EPS
Revenue vs. Earnings
Revenue 13.23B
Earnings 4.48B
Q224
Q324
Q424
Q125
0
5B
10B
Analyst Recommendations
Strong Buy
Buy
Hold
Underperform
Sell
Analyst Price Targets
78.72 Low 98.58 Average
97.83 Current
118.62 High
View More
People Also Watch
ROG.SW
Roche Holding AG
259.90 -2.00%
NESN.SW
Nestlé S.A.
71.28 -0.47%
ZURN.SW
Zurich Insurance Group AG
553.80 -1.07%
SREN.SW
Swiss Re AG
140.35 -0.50%
UBSG.SW
UBS Group AG
33.18 -1.04%
Copyright © 2025 Yahoo. All rights reserved.
What's trending Dow Jones
S&P 500
DAX Index
Nvidia
Tesla
DJT
Tariffs
Explore more Mortgages
Credit Cards
Sectors
Crypto Heatmap
Financial News
About Data Disclaimer
Help
Feedback
Sitemap
Licensing
What's New
About Our Ads
Premium Plans
Terms
and Privacy Policy
Privacy Dashboard
More Info
U.S. markets closed
US
Europe
Asia
Cryptocurrencies
Rates
Commodities
Currencies
S&P Futures
6,702.00 +9.75 (+0.15%)
Dow Futures
46,504.00 +63.00 (+0.14%)
Nasdaq Futures
24,776.00 +36.75 (+0.15%)
Russell 2000 Futures
2,459.50 +5.40 (+0.22%)
VIX
16.18 -0.46 (-2.76%)
Gold
3,772.50 +4.40 (+0.12%)
Portfolio
Portfolio
Sign in to access your portfolio Sign in
Top gainers
QURE uniQure N.V. 47.50 +33.84 (+247.73%)
CDTX Cidara Therapeutics, Inc. 88.58 +15.09 (+20.53%)
OPEN Opendoor Technologies Inc. 8.23 +1.15 (+16.24%)
SLNO Soleno Therapeutics, Inc. 64.50 +7.65 (+13.46%)
IREN IREN Limited 47.14 +5.37 (+12.86%)
Top losers
FCX Freeport-McMoRan Inc. 37.67 -7.69 (-16.95%)
QMMM QMMM Holdings Limited 95.00 -14.00 (-12.84%)
WOR Worthington Enterprises, Inc. 53.29 -6.97 (-11.57%)
SOC Sable Offshore Corp. 21.76 -2.73 (-11.15%)
ALAB Astera Labs, Inc. 205.27 -24.84 (-10.79%)
Most active
OPEN Opendoor Technologies Inc. 8.23 +1.15 (+16.24%)
PLUG Plug Power Inc. 2.4000 -0.1300 (-5.14%)
INTC Intel Corporation 31.22 +1.88 (+6.41%)
RGTI Rigetti Computing, Inc. 31.64 +0.20 (+0.64%)
SNAP Snap Inc. 8.22 -0.20 (-2.38%)
Earnings events
My earnings events
Earnings events
Trending tickers
INTC Intel Corporation 31.22 +1.88 (+6.41%)
QURE uniQure N.V. 47.50 +33.84 (+247.73%)
BABA Alibaba Group Holding Limited 176.44 +13.36 (+8.19%)
OPEN Opendoor Technologies Inc. 8.23 +1.15 (+16.24%)
FCX Freeport-McMoRan Inc. 37.67 -7.69 (-16.95%)
Top economic events
Top economic events
United States
MBA 30-Yr Mortgage Rate
Sep 24, 2025, 7:00 AM EDT Prior: P: 6.39 New: N: 6.34
MBA 30-Yr Mortgage Rate
Sep 24, 2025, 7:00 AM EDT Prior: Prior: 6.39 New: New: 6.34
Mortgage Market Index
Sep 24, 2025, 7:00 AM EDT Prior: P: 386.1 New: N: 388.3
Mortgage Market Index
Sep 24, 2025, 7:00 AM EDT Prior: Prior: 386.1 New: New: 388.3
Edit your Dock
Terms
and Privacy Policy
Privacy Dashboard
Ad Terms
Feedback
More Info